Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

January 1, 2005

Primary Completion Date

August 1, 2008

Study Completion Date

August 1, 2008

Conditions
Myelodysplastic Syndromes
Interventions
DRUG

azacitidine

"Azacitidine is administered subcutaneously~Total of 18 cycles on treatment or early discontinuation."

Trial Locations (31)

15224

Western Pennsylvania Cancer Institute, Pittsburgh

20010

Washington Cancer Institute, Washington D.C.

23502

Virginia Oncology Associates - Lake Wright Cancer Center, Norfolk

34652

Florida Cancer Institute, New Port Richey

34761

Cancer Centers of Florida, P.A., Ocoee

37203

The Sarah Cannon Research Institute, Nashville

37604

McLeod Cancer and Blood Center, Johnson City

45409

Greater Dayton Cancer Center, Kettering

46227

Central Indiana Cancer Centers, Indianapolis

48910

Great Lakes Cancer Institute Breslin Cancer Center, Lansing

57105

Avera Cancer Institute Leukemia-Bone Marrow Transplant Center, Sioux Falls

57401

Oncology Services of Aberdeen, Aberdeen

60435

Joliet Oncology-Hematology Associates, Ltd., Joliet

63141

The Center for Cancer Care and Research, St Louis

70115

Hematology & Oncology Specialists LLC, Metairie

75230

Texas Cancer Center at Medical City, Dallas

76022

Texas Oncology, P.A., Bedford

76104

Texas Oncology, PA, Fort Worth

78229

Cancer Care Centers of South Texas - HOAST, San Antonio

78624

San Antonio Tumor & Blood Clinic, Fredericksburg

80218

Rocky Mountain Cancer Centers, LLP, Denver

80907

Cancer Center of Colorado Springs, The Oncology Clinic, PC, Colorado Springs

90211

Tower Cancer Research Foundation, Beverly Hills

93309

Comprehensive Blood and Cancer Center, Research Department, Bakersfield

98026

Puget Sound Cancer Center, Edmonds

98133

Puget Sound Cancer Center, Seattle

98166

Highline Medical Oncology, Burien

98684

Northwest Cancer Specialists, P.C., Vancouver

99218

Cancer Care Northwest, Spokane

61615-7828

Oncology/Hematology Associates of Central Illinois, PC, Peoria

07601

Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY